Cargando…
Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial
BACKGROUND: The monthly dapivirine vaginal ring provides partial protection against HIV, and a longer duration ring may reduce user burden and improve adherence. We examined acceptability and preference for 3-month versus 1-month rings for HIV-1 risk reduction in a phase 1 clinical trial. MATERIALS...
Autores principales: | Roberts, Sarah T., Hawley, Imogen, Luecke, Ellen, Mensch, Barbara, Wagner, Theresa, Hoesley, Craig, McClure, Tara, Dominguez Islas, Clara P., Piper, Jeanna M., Liu, Albert Y., van der Straten, Ariane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299526/ https://www.ncbi.nlm.nih.gov/pubmed/34665672 http://dx.doi.org/10.1089/jwh.2021.0121 |
Ejemplares similares
-
Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring
por: Stoner, Marie C. D., et al.
Publicado: (2022) -
Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States
por: Liu, Albert Y, et al.
Publicado: (2021) -
Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women
por: Shapley-Quinn, Mary Kate, et al.
Publicado: (2022) -
Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability
por: Shapley-Quinn, Mary Kate, et al.
Publicado: (2023) -
Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world
por: Ridgeway, Kathleen, et al.
Publicado: (2022)